|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク，インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
|
BR9806793A
(pt)
|
1997-01-22 |
2000-05-16 |
Univ Texas |
Processos e composições de fator tissular para coagulação e tratamento de tumores.
|
|
US20050260177A1
(en)
*
|
1998-06-05 |
2005-11-24 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US7264801B2
(en)
*
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
|
US20020172678A1
(en)
*
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
|
EP1131106B1
(en)
*
|
1998-11-12 |
2009-06-24 |
Novolytics Inc. |
Compositions and methods for producing vascular occlusion
|
|
EP1187632B1
(en)
*
|
1999-05-14 |
2008-12-03 |
Genentech, Inc. |
TREATMENT WITH ANTI-ErbB2 ANTIBODIES
|
|
US20030143233A1
(en)
*
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US20030103948A1
(en)
*
|
1999-06-07 |
2003-06-05 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US7144991B2
(en)
|
1999-06-07 |
2006-12-05 |
Aletheon Pharmaceuticals, Inc. |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US6924359B1
(en)
*
|
1999-07-01 |
2005-08-02 |
Yale University |
Neovascular-targeted immunoconjugates
|
|
CA2377381C
(en)
*
|
1999-07-01 |
2013-06-11 |
Yale University |
Neovascular-targeted immunoconjugates
|
|
US6693176B1
(en)
*
|
1999-07-23 |
2004-02-17 |
University Of Massachusetts |
Antitumor antibodies, proteins, and uses thereof
|
|
DE60045247D1
(de)
*
|
1999-07-28 |
2010-12-30 |
Genentech Inc |
Zusammensetzungen und verfahren zur behandlung von tumoren
|
|
AU6820000A
(en)
|
1999-08-31 |
2001-03-26 |
Novozymes A/S |
Novel proteases and variants thereof
|
|
US7217554B2
(en)
|
1999-08-31 |
2007-05-15 |
Novozymes A/S |
Proteases and variants thereof
|
|
US6905683B2
(en)
|
2000-05-03 |
2005-06-14 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII variants
|
|
IL152656A0
(en)
|
2000-05-19 |
2003-06-24 |
Genentech Inc |
Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
|
|
TWI317285B
(en)
|
2000-07-28 |
2009-11-21 |
Dainippon Sumitomo Pharma Co |
New use and kit for remedies for cancer
|
|
US7176288B2
(en)
|
2000-09-13 |
2007-02-13 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII variants
|
|
US7173000B2
(en)
|
2000-11-09 |
2007-02-06 |
The Scripps Research Institute |
Modified factor VIIa
|
|
US7622437B2
(en)
*
|
2000-11-20 |
2009-11-24 |
The Board Of Trustees Of The University Of Illinois |
Tissue factor compositions and methods
|
|
US20040002450A1
(en)
*
|
2000-12-29 |
2004-01-01 |
Janette Lazarovits |
Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
|
|
JP2004524023A
(ja)
*
|
2000-12-29 |
2004-08-12 |
バイオ テクノロジー ジェネラル コーポレイション |
選択的癌療法のための特異的ヒト抗体
|
|
US20040001822A1
(en)
*
|
2000-12-29 |
2004-01-01 |
Avigdor Levanon |
Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
|
|
US20040001839A1
(en)
*
|
2000-12-29 |
2004-01-01 |
Avigdor Levanon |
Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
|
|
US7132510B2
(en)
*
|
2000-12-29 |
2006-11-07 |
Bio-Technology General (Israel) Ltd. |
Specific human antibodies for selective cancer therapy
|
|
TWI296196B
(en)
*
|
2001-04-06 |
2008-05-01 |
Wyeth Corp |
Antineoplastic combinations
|
|
TWI233359B
(en)
*
|
2001-04-06 |
2005-06-01 |
Wyeth Corp |
Pharmaceutical composition for treating neoplasm
|
|
US7419949B2
(en)
*
|
2001-07-16 |
2008-09-02 |
Novo Noridsk Healthcare A/G |
Single-dose administration of factor VIIa
|
|
WO2003028840A2
(en)
*
|
2001-09-27 |
2003-04-10 |
Board Of Regents, The University Of Texas System |
Combined compositions and methods for tumor vasculature coagulation and treatment
|
|
US7052868B2
(en)
|
2001-09-27 |
2006-05-30 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
|
US7205275B2
(en)
|
2001-10-11 |
2007-04-17 |
Amgen Inc. |
Methods of treatment using specific binding agents of human angiopoietin-2
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
US7399743B2
(en)
*
|
2001-10-26 |
2008-07-15 |
The Scripps Research Institute |
Targeted thrombosis
|
|
US6960657B2
(en)
|
2001-11-02 |
2005-11-01 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
|
US7491690B2
(en)
*
|
2001-11-14 |
2009-02-17 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
|
AU2003202903A1
(en)
*
|
2002-01-03 |
2003-07-24 |
Tanox, Inc. |
Human mast cell-expressed membrane proteins
|
|
AU2003215280A1
(en)
*
|
2002-02-15 |
2003-09-09 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
|
US20040102402A1
(en)
*
|
2002-11-22 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of tissue factor expression
|
|
WO2005014775A2
(en)
*
|
2002-06-28 |
2005-02-17 |
University Of Florida Research Foundation, Inc. |
Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a
|
|
US20040208877A1
(en)
*
|
2002-07-01 |
2004-10-21 |
Avigdor Levanon |
Antibodies and uses thereof
|
|
US20040202665A1
(en)
*
|
2002-07-01 |
2004-10-14 |
Janette Lazarovits |
Compositions and methods for therapeutic treatment
|
|
KR20110025885A
(ko)
|
2002-07-15 |
2011-03-11 |
더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 |
포스파티딜에탄올아민에 결합하는 펩타이드, 및 바이러스 감염을 치료하는데 있어서 이의 용도
|
|
US7534761B1
(en)
|
2002-08-21 |
2009-05-19 |
North Western University |
Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom
|
|
US6911323B2
(en)
|
2002-09-25 |
2005-06-28 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
|
AU2003298647A1
(en)
*
|
2002-11-14 |
2004-06-15 |
Claussen, Randal, C. |
Synthesis and self-assembly of abc triblock bola peptide
|
|
US20040115204A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Fanger Gary R. |
Antibodies to treat cancer
|
|
MXPA05008483A
(es)
|
2003-02-11 |
2006-03-10 |
Univ Northwestern |
Metodos y materiales para revestimientos de superficie nanocristalinos y union de nanofibras de anfililos peptidicos sobre las mismas.
|
|
DE602004021099D1
(de)
*
|
2003-03-20 |
2009-06-25 |
Bayer Healthcare Llc |
Fvii oder fviia varianten
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
DE602004031390D1
(de)
*
|
2003-05-06 |
2011-03-24 |
Syntonix Pharmaceuticals Inc |
Gerinnungsfaktor VII-Fc chimäre Proteine zur Behandlung von hämostatischen Krankheiten
|
|
US20110002978A1
(en)
|
2003-06-17 |
2011-01-06 |
Harrison Roger G |
Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof
|
|
US20070207158A1
(en)
*
|
2003-06-17 |
2007-09-06 |
Harrison Roger G |
Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
|
|
US20050069955A1
(en)
*
|
2003-06-30 |
2005-03-31 |
Daniel Plaksin |
Antibodies and uses thereof
|
|
US20050152906A1
(en)
*
|
2003-06-30 |
2005-07-14 |
Avigdor Levanon |
Specific human antibodies
|
|
EP1660658A2
(en)
*
|
2003-08-06 |
2006-05-31 |
Hans Peter B. Prydz |
The use of sirna silencing in the prevention of metastasis
|
|
DE10338733A1
(de)
*
|
2003-08-22 |
2005-03-24 |
Berdel, Wolfgang E., Prof. Dr.med. |
Fusionspolypeptide und deren Verwendung für die antivaskuläre Tumortherapie
|
|
JP4824559B2
(ja)
|
2003-09-09 |
2011-11-30 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
凝固因子ｖｉｉポリペプチド
|
|
ES2380340T3
(es)
|
2003-12-05 |
2012-05-10 |
Northwestern University |
Anfífilos peptídicos auto-ensamblantes y métodos relacionados para la administración de factores de crecimiento
|
|
KR20070004561A
(ko)
|
2003-12-05 |
2007-01-09 |
노오쓰웨스턴 유니버시티 |
분지형 펩티드 친양매성 화합물들, 그들의 관련된 에피토프화합물들 및 자가조립된 구조들
|
|
PL1711528T3
(pl)
|
2003-12-23 |
2012-11-30 |
Genentech Inc |
Leczenie nowotworu nowymi przeciwciałami monoklonalnymi anty-IL13
|
|
US20060078542A1
(en)
*
|
2004-02-10 |
2006-04-13 |
Mah Cathryn S |
Gel-based delivery of recombinant adeno-associated virus vectors
|
|
EP1732594A4
(en)
*
|
2004-03-18 |
2007-10-17 |
St Lukes Hospital |
METHOD FOR THE ADMINISTRATION OF AGENTS WITH DELAYED RELEASE
|
|
US7556150B2
(en)
*
|
2004-06-07 |
2009-07-07 |
Duramed Pharmaceuticals, Inc. |
Dispenser for progestin used for acute and maintenance treatment of DUB
|
|
WO2006036834A2
(en)
*
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
MODIFIED Fc MOLECULES
|
|
EP1812032A4
(en)
*
|
2004-10-27 |
2009-09-02 |
Univ Illinois |
TISSUE FACTOR COMPOSITION AND RELATED METHODS
|
|
EP1853917A4
(en)
*
|
2005-03-04 |
2008-09-10 |
Univ Northwestern |
ANGIOGENIC HEPARIN BINDING EPITOPES, PEPTIDE AMPHIPHILES, SELF-ASSEMBLED COMPOSITIONS AND METHODS OF USE THEREOF
|
|
US7393833B2
(en)
*
|
2005-03-09 |
2008-07-01 |
The Board Of Regents Of The University Of Oklahoma |
Chimeric proteins with phosphatidylserine binding domains
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
US8076295B2
(en)
*
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
|
GB0723712D0
(en)
*
|
2007-12-04 |
2008-01-16 |
Apitope Technology Bristol Ltd |
Peptides
|
|
NZ588587A
(en)
|
2008-03-19 |
2013-01-25 |
China Synthetic Rubber Corp |
Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
|
|
NZ594698A
(en)
*
|
2009-02-05 |
2013-08-30 |
Pierre Philippart |
Method and means for producing tissues and tissues obtained
|
|
EP2419116A1
(en)
*
|
2009-04-13 |
2012-02-22 |
North Western University |
Novel peptide-based scaffolds for cartilage regeneration and methods for their use
|
|
CN102153653B
(zh)
*
|
2010-12-30 |
2012-08-15 |
厦门大学 |
肿瘤血管靶向多肽与组织因子的融合蛋白及其制备方法
|
|
CN105722532A
(zh)
|
2013-09-13 |
2016-06-29 |
豪夫迈·罗氏有限公司 |
包含纯化的重组多肽的方法和组合物
|
|
BR112016004437A2
(pt)
|
2013-09-13 |
2017-10-17 |
Genentech Inc |
métodos de imunoteste e de seleção de linhagem de células, anticorpos e kit
|
|
US9493552B2
(en)
|
2013-11-15 |
2016-11-15 |
China Synthetic Rubber Corporation |
Therapeutic biologic for treatment of hepatocellular carcinoma
|
|
US9987241B2
(en)
|
2014-09-25 |
2018-06-05 |
The Board Of Regents Of The University Of Oklahoma |
Enzyme conjugate and prodrug cancer therapy
|
|
CN104387474B
(zh)
*
|
2014-11-17 |
2018-01-23 |
北京华安科创生物技术有限公司 |
一种肿瘤血管梗塞剂多肽、基因、表达载体及其应用
|
|
CN106699875A
(zh)
*
|
2017-02-23 |
2017-05-24 |
青岛古高生物科技有限公司 |
一种人重组组织因子及其基因、表达载体、宿主菌和表达方法
|
|
WO2020032951A1
(en)
|
2018-08-09 |
2020-02-13 |
The Board Of Regents Of The University Of Oklahoma |
Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same
|
|
CN108948209A
(zh)
*
|
2018-07-17 |
2018-12-07 |
广西医科大学 |
一种cd105单链抗体-es融合蛋白的制备方法和用途
|
|
CN109999182B
(zh)
*
|
2019-03-29 |
2023-03-07 |
四川大学华西医院 |
凝血因子在制备抗肿瘤药物中的应用
|
|
US20250136663A1
(en)
*
|
2023-10-31 |
2025-05-01 |
Immunitybio, Inc. |
Multi-chain chimeric polypeptides and uses thereof
|